Denali Therapeutics Inc. (DNLI) has a market capitalization of $3.2B and trades at $20.16. The 52-week range is 10.57-23.77.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.8, Earnings Per Share (EPS) of $-2.97.
The stock has a beta of 1.10, operates in the Healthcare sector.
